Cargando…

Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics

Hepatitis B virus reactivation (HBVr) can occur in patients treated with immunosuppressive medications. Risk stratification for HBVr based on hepatitis B virus (HBV) serology and viral load is an important strategy to determine appropriate HBV monitoring and antiviral prophylaxis use. Recent advance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akiyama, Shintaro, Cotter, Thomas G, Sakuraba, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130042/ https://www.ncbi.nlm.nih.gov/pubmed/34040324 http://dx.doi.org/10.3748/wjg.v27.i19.2312

Ejemplares similares

Hepatitis B virus reactivation in rheumatoid arthritis
por: Wu, Ya-Li, et al.
Publicado: (2022)

Pathogenesis of autoimmune hepatitis
por: Fan, Jun-Hua, et al.
Publicado: (2021)

Autoimmune hepatitis and liver transplantation: Indications, and recurrent and de novo autoimmune hepatitis
por: Harputluoglu, Murat, et al.
Publicado: (2022)

Screening and prevention of hepatitis C virus reactivation during chemotherapy
por: Li, Yuan-Rung, et al.
Publicado: (2021)

Tumor necrosis family receptor superfamily member 9/tumor necrosis factor receptor-associated factor 1 pathway on hepatitis C viral persistence and natural history
por: Peña-Asensio, Julia, et al.
Publicado: (2020)

Distinct roles of interleukin-17 and T helper 17 cells among autoimmune diseases
por: Akiyama, Shintaro, et al.
Publicado: (2021)

Seronegative autoimmune hepatitis in childhood
por: Islek, Ali, et al.
Publicado: (2023)

Hepatitis B virus infection reactivation in patients under immunosuppressive therapies: Pathogenesis, screening, prevention and treatment
por: Spera, Anna Maria
Publicado: (2022)

Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNA
por: Sekiba, Kazuma, et al.
Publicado: (2018)

Autoimmune hepatitis: Appraisal of current treatment guidelines
por: Lowe, Dhruv, et al.
Publicado: (2018)

Health-related quality of life in autoimmune hepatitis
por: Snijders, Romée JALM, et al.
Publicado: (2021)

Drug-induced autoimmune hepatitis: A minireview
por: Tan, Chin Kimg, et al.
Publicado: (2022)

Autoimmune hepatitis and IgG4-related disease
por: Minaga, Kosuke, et al.
Publicado: (2019)

Autoimmune hepatitis in genetic syndromes: A literature review
por: Capra, Anna Paola, et al.
Publicado: (2021)

Infantile giant cell hepatitis with autoimmune hemolytic anemia
por: Poddighe, Dimitri, et al.
Publicado: (2021)

Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy
por: Shih, Chih-An, et al.
Publicado: (2021)

Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure
por: Shinn, Brianna J, et al.
Publicado: (2019)

Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settings
por: Said, Zeinab Nabil Ahmed, et al.
Publicado: (2022)

Impact of hepatitis B virus infection on hepatic metabolic signaling pathway
por: Shi, Yi-Xian, et al.
Publicado: (2016)

Treatment of hepatitis B virus infection in children and adolescents
por: Stinco, Mariangela, et al.
Publicado: (2021)

Prevention of vertical transmission of hepatitis B virus infection
por: Veronese, Piero, et al.
Publicado: (2021)

Human immune repertoire in hepatitis B virus infection
por: Zhan, Qiao, et al.
Publicado: (2021)

Exit strategies in inflammatory bowel disease: Looking beyond anti-tumor necrosis factors
por: Crispino, Federica, et al.
Publicado: (2023)

Hepatitis B virus-persistent infection and innate immunity defect: Cell-related or virus-related?
por: Tang, Jian, et al.
Publicado: (2018)

The relevance of complement to virus biology
por: Blue, Clare E, et al.
Publicado: (2004)

Chronic hepatitis B: New potential therapeutic drugs target
por: Leowattana, Wattana, et al.
Publicado: (2022)

Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation
por: Crismale, James F, et al.
Publicado: (2019)

Metabolic aspects of hepatitis C virus
por: El-Kassas, Mohamed, et al.
Publicado: (2022)

Biological and historical overview of Zika virus
por: Armstrong, Najealicka, et al.
Publicado: (2017)

Elucidation of the early infection machinery of hepatitis B virus by using bio-nanocapsule
por: Liu, Qiushi, et al.
Publicado: (2016)

Interaction between hepatitis B virus and SARS-CoV-2 infections
por: Xiang, Tian-Dan, et al.
Publicado: (2021)

Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma
por: Gnyawali, Bipul, et al.
Publicado: (2022)

The risk of respiratory tract infections and interstitial lung disease with interleukin 12/23 and interleukin 23 antagonists in patients with autoimmune diseases: A systematic review and meta-analysis
por: Akiyama, Shintaro, et al.
Publicado: (2021)

Evolving roles of magnifying endoscopy and endoscopic resection for neoplasia in inflammatory bowel diseases
por: Akiyama, Shintaro, et al.
Publicado: (2022)

Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases
por: Akiyama, Shintaro, et al.
Publicado: (2022)

Pregnancy and medications for inflammatory bowel disease: An updated narrative review
por: Akiyama, Shintaro, et al.
Publicado: (2023)

Functional interaction of endoplasmic reticulum stress and hepatitis B virus in the pathogenesis of liver diseases
por: Kim, So Young, et al.
Publicado: (2017)

How Extracellular Reactive Oxygen Species Reach Their Intracellular Targets in Plants
por: Lee, Jinsu, et al.
Publicado: (2023)

Current treatment for hepatitis C virus/human immunodeficiency virus coinfection in adults
por: Laiwatthanapaisan, Ratchapong, et al.
Publicado: (2021)

Research progress on reactive oxygen species production mechanisms in tumor sonodynamic therapy
por: Dong, He-Qin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jea06jkq1bbjru5vhij88jrt9d